You just read:

AveXis presented robust data at AAN demonstrating efficacy of Zolgensma® in broad spectrum of spinal muscular atrophy (SMA) patients

News provided by

Novartis Pharmaceuticals Corporation

May 05, 2019, 11:30 ET